116 related articles for article (PubMed ID: 25070816)
1. L-arginine enhances arginine deiminase induced human lymphoma cell growth inhibition through NF-kBp65 and p53 expression in vitro.
Shu XL; Liu XL; Zhong JX; Liu J
Eur Rev Med Pharmacol Sci; 2014; 18(15):2124-31. PubMed ID: 25070816
[TBL] [Abstract][Full Text] [Related]
2. Extrinsic nitric oxide donor partially reverses arginine deiminase induced cell growth inhibition through NFkappaB and Bcl-X L.
Seo JH; Sung HJ; Choi CW; Kim BS; Shin SW; Kim YH; Min BH; Kim JS
Invest New Drugs; 2008 Jun; 26(3):277-82. PubMed ID: 18180877
[TBL] [Abstract][Full Text] [Related]
3. Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells.
Manca A; Sini MC; Izzo F; Ascierto PA; Tatangelo F; Botti G; Gentilcore G; Capone M; Mozzillo N; Rozzo C; Cossu A; Tanda F; Palmieri G
Oncol Rep; 2011 Jun; 25(6):1495-502. PubMed ID: 21424129
[TBL] [Abstract][Full Text] [Related]
4. Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS-mediated neurotoxicity in a coculture of neurons and microglia.
Yu HH; Wu FL; Lin SE; Shen LJ
J Neurosci Res; 2008 Oct; 86(13):2963-72. PubMed ID: 18627024
[TBL] [Abstract][Full Text] [Related]
5. Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo.
Fiedler T; Strauss M; Hering S; Redanz U; William D; Rosche Y; Classen CF; Kreikemeyer B; Linnebacher M; Maletzki C
Cancer Biol Ther; 2015; 16(7):1047-55. PubMed ID: 25774632
[TBL] [Abstract][Full Text] [Related]
6. Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanoma.
Stelter L; Evans MJ; Jungbluth AA; Longo VA; Zanzonico P; Ritter G; Bomalaski JS; Old L; Larson SM
Mol Imaging; 2013; 12(1):67-73. PubMed ID: 23348793
[TBL] [Abstract][Full Text] [Related]
7. Purification, immobilization, and biochemical characterization of l-arginine deiminase from thermophilic Aspergillus fumigatus KJ434941: anticancer activity in vitro.
El-Sayed AS; Hassan MN; Nada HM
Biotechnol Prog; 2015; 31(2):396-405. PubMed ID: 25582958
[TBL] [Abstract][Full Text] [Related]
8. Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidis.
Wang M; Basu A; Palm T; Hua J; Youngster S; Hwang L; Liu HC; Li X; Peng P; Zhang Y; Zhao H; Zhang Z; Longley C; Mehlig M; Borowski V; Sai P; Viswanathan M; Jang E; Petti G; Liu S; Yang K; Filpula D
Bioconjug Chem; 2006; 17(6):1447-59. PubMed ID: 17105223
[TBL] [Abstract][Full Text] [Related]
9. Regulation of apoptosis in human gastric cancer cell line SGC-7901 by L-arginine.
Shu XL; Xu H; Yu TT; Zhong JX; Lei T
Panminerva Med; 2014 Sep; 56(3):227-31. PubMed ID: 24561640
[TBL] [Abstract][Full Text] [Related]
10. Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity.
El-Sayed ASA; Shindia AA; Zeid AAA; Yassin AM; Sitohy MZ; Sitohy B
Enzyme Microb Technol; 2019 Dec; 131():109432. PubMed ID: 31615671
[TBL] [Abstract][Full Text] [Related]
11. The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials.
Synakiewicz A; Stachowicz-Stencel T; Adamkiewicz-Drozynska E
Expert Opin Investig Drugs; 2014 Nov; 23(11):1517-29. PubMed ID: 24965808
[TBL] [Abstract][Full Text] [Related]
12. Purification of a dimeric arginine deiminase from Enterococcus faecium GR7 and study of its anti-cancerous activity.
Kaur B; Kaur R
Protein Expr Purif; 2016 Sep; 125():53-60. PubMed ID: 26363115
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma.
Kim JH; Kim JH; Yu YS; Kim DH; Min BH; Kim KW
Oncol Rep; 2007 Dec; 18(6):1373-7. PubMed ID: 17982619
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Arginine Deiminase from
Mendoza RM; Song JH; Jung YT; Paik HD; Park YS; Kang DK
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673749
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of arginine deiminase treatment in melanoma xenografts using (18)F-FLT PET.
Stelter L; Fuchs S; Jungbluth AA; Ritter G; Longo VA; Zanzonico P; Raschzok N; Sauer IM; Bomalaski JS; Larson SM
Mol Imaging Biol; 2013 Dec; 15(6):768-75. PubMed ID: 23722880
[TBL] [Abstract][Full Text] [Related]
16. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA
Cancer Res; 2002 Oct; 62(19):5443-50. PubMed ID: 12359751
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production.
Dillon BJ; Holtsberg FW; Ensor CM; Bomalaski JS; Clark MA
Med Sci Monit; 2002 Jul; 8(7):BR248-53. PubMed ID: 12118186
[TBL] [Abstract][Full Text] [Related]
18. Intracellular expression of arginine deiminase activates the mitochondrial apoptosis pathway by inhibiting cytosolic ferritin and inducing chromatin autophagy.
Feng Q; Bian X; Liu X; Wang Y; Zhou H; Ma X; Quan C; Yao Y; Zheng Z
BMC Cancer; 2020 Jul; 20(1):665. PubMed ID: 32677906
[TBL] [Abstract][Full Text] [Related]
19. Rapid evolution of arginine deiminase for improved anti-tumor activity.
Ni Y; Liu Y; Schwaneberg U; Zhu L; Li N; Li L; Sun Z
Appl Microbiol Biotechnol; 2011 Apr; 90(1):193-201. PubMed ID: 21221572
[TBL] [Abstract][Full Text] [Related]
20. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]